Invivyd Prices $50 Million Offering of Stock, Warrants
MT Newswires Live
Aug 21
Invivyd (IVVD) said late Wednesday it priced an underwritten public offering of 74.8 million common shares at $0.52 per share and, in lieu of common shares to certain investors, pre-funded warrants to purchase 21.3 million shares at $0.5199 per warrant.
The company expects gross proceeds of $50 million.
The underwriters have been granted a 30-day option to purchase up to 14.4 million additional shares.
Net proceeds will be used to fund the company's clinical program, research and development, working capital and general corporate purposes, the company said.
Closing of the offering is expected on Friday, subject to customary conditions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.